<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04911569</url>
  </required_header>
  <id_info>
    <org_study_id>Cryo_210510_V02</org_study_id>
    <nct_id>NCT04911569</nct_id>
  </id_info>
  <brief_title>Cryoneurolysis for Cutaneous Neuropathic Pain</brief_title>
  <official_title>The Effect of Ultrasound-guided Cryoneurolysis on Persistent Cutaneous Neuropathic Pain After Surgery and Trauma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Feasibility study with 25 patients investigating the effect of cryoneurolysis on persistent&#xD;
      cutaneous neuropathic pain after surgery and trauma. All patients receive active treatment&#xD;
      (cryoneurolysis). The study design is unblinded, non-randomized, non-controlled.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">June 7, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Non-blinded, non-randomized, non-controlled</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success of cryoneurolysis</measure>
    <time_frame>1 hour after cryoneurolysis</time_frame>
    <description>Frequency of patients with &gt; 50% reduction of neuropathic pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Axonal loss estimated before cryoneurolysis</measure>
    <time_frame>Maximum one year prior to the cryoneurolysis procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hyperalgesia for pinprick</measure>
    <time_frame>1 hour after cryo procedure compared to baseline</time_frame>
    <description>Visual Analogue Scale (VAS) score (0-100)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Allodynia for brush</measure>
    <time_frame>1 hour after cryo procedure compared to baseline</time_frame>
    <description>VAS score (0-100)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of NRS score &lt; 4</measure>
    <time_frame>1 hour, 2 weeks and 1,2,3,4,5 and 6 months after cryo procedure</time_frame>
    <description>Numeric Rating Scale (NRS) score (0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>1 hour, 2 weeks and 1,2,3,4,5 and 6 months after cryoneurolysis procedure</time_frame>
    <description>NRS score (0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of freedom of pain (number of days after the cryoneurolysis procedure)</measure>
    <time_frame>Maximum follow-up until 12 months after cryoneurolysis procedure</time_frame>
    <description>NRS &lt; 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of neuropathic pain score DN-4</measure>
    <time_frame>1 hour, 2 weeks and 1,2,3,4,5 and 6 months after cryo procedure</time_frame>
    <description>DN-4 = Douleur Neuropathique en 4 Questions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction at completion of cryo procedure</measure>
    <time_frame>From skin insertion of cryo probe to withdrawal of cryo probe</time_frame>
    <description>NRS score (0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in muscle strength of relevant muscle groups</measure>
    <time_frame>1 hour after cryoneurolysis compared to baseline</time_frame>
    <description>Handheld dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure time for cryoneurolysis</measure>
    <time_frame>From skin insertion of cryo probe to withdrawal of cryo probe</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain related medication</measure>
    <time_frame>2 weeks and 1,2,3,4,5 and 6 months after cryo procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PGIC</measure>
    <time_frame>2 weeks and 1,2,3,4,5 and 6 months after cryo procedure</time_frame>
    <description>Patient Global Impression of Change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>1 hour, 2 weeks and 1,2,3,4,5 and 6 months after cryo procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Neuropathic Pain</condition>
  <arm_group>
    <arm_group_label>Cryoneurolysis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All 25 patients will receive cryoneurolysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryoneurolysis</intervention_name>
    <description>Cryoneurolysis</description>
    <arm_group_label>Cryoneurolysis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 17 years&#xD;
&#xD;
          -  ASA (American Society of Anesthesiologists) physical status classification system&#xD;
             I-III&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  Capable of subjective evaluation of pain&#xD;
&#xD;
          -  Capable of reading and understanding Danish and informed written consent&#xD;
&#xD;
          -  Average pain intensity &gt;49/100 on VAS in the primary focal pain area for a minimum of&#xD;
             6 months at the time of inclusion&#xD;
&#xD;
          -  Relevant injury (surgery or trauma) of peripheral nerves&#xD;
&#xD;
          -  Plausible cutaneous location of pain&#xD;
&#xD;
          -  In the area of pain, at least one of the following (1-8): (1) Hypo/anesthesia for&#xD;
             touch/brush (2) Hypo/anesthesia for cold (3) Hypo/anesthesia for warmth (4)&#xD;
             Hypo/anesthesia for pinprick (5) Allodynia for touch/brush (6) Allodynia for cold (7)&#xD;
             Allodynia for warmth (8) Hyperalgesia for pinprick&#xD;
&#xD;
          -  Neuropathic pain score (Douleur Neuropathique en 4 Questions, DN-4) &gt;3/10&#xD;
&#xD;
          -  Definitive diagnosis of neuropathic pain (Finnerup et al 2016)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to cooperate&#xD;
&#xD;
          -  Inability to understand Danish&#xD;
&#xD;
          -  Allergy to local anesthetic&#xD;
&#xD;
          -  Infection in the area of cryo probe insertion&#xD;
&#xD;
          -  Significant competitive chronic pain&#xD;
&#xD;
          -  Progressive neurologic disease&#xD;
&#xD;
          -  Increased risk at needle insertion and cold exposure (e.g. Raynaud, coagulopathies)&#xD;
&#xD;
          -  Uncontrolled severe systemic disease&#xD;
&#xD;
          -  Implanted electronic devices unless approved by the relevant medical specialist&#xD;
&#xD;
          -  Previous cryoneurolysis with no relevant effect for the same neuropathic pain&#xD;
&#xD;
          -  Previous interventional pain therapy (e.g. spinal cord stimulation) with no relevant&#xD;
             effect for the same neuropathic pain&#xD;
&#xD;
          -  Expected duration of life &lt; 2 years&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Abuse of alcohol, narcotics or medicine&#xD;
&#xD;
          -  Current psychiatric disease&#xD;
&#xD;
          -  Inclusion in other clinical trials&#xD;
&#xD;
          -  Ongoing patient complaint&#xD;
&#xD;
          -  Body mass index &lt; 18.5 or &gt; 34.9 kg/m2&#xD;
&#xD;
          -  Change of pain therapy within the last 28 days prior to inclusion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas F Bendtsen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas F Bendtsen, MD, PhD</last_name>
    <phone>+4576484809</phone>
    <email>tfb@dadlnet.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <state>Region Midtjylland</state>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas F Bendtsen, MD, PhD</last_name>
      <phone>+4576484809</phone>
      <email>tfb@dadlnet.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 19, 2021</study_first_submitted>
  <study_first_submitted_qc>June 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 3, 2021</study_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

